Anti-radiation drug could work days after exposure, says Dr. Tigyi
Cells try to repair damage to their DNA after radiation exposure, says Gábor Tigyi at the University of Tennessee Health Science Center
Search Results for
Artistry and Science: The Penczner Legacy in Memphis
Hungarian-born Penczner and his German wife, Jolanda, were part of a lively community of Central European expats in Memphis, a group that also included Dr. Gabor Tigyi, a fellow Hungarian and chair of the Department of Physiology at UT Health Science Center.
UT Health Science Center researchers partner on multi-institutional $20 million award to develop new radiopharmaceutical cancer therapie
UT Health Science Center researchers Gabor Tigyi, MD, PhD, Harriet Van Vleet Endowment Professor in Basic Oncology Research, Junming Yue, PhD, associate professor in the Department of Pathology, Sue Chin Lee, PhD, in the Department of Physiology, and David Schwartz, MD, chair of the Department of Radiation Oncology, are part of a scientific leadership group… Read More
Collaborative project gets $20 million to develop new radiopharmaceutical cancer therapies
UT Health Science Center researchers Gabor Tigyi, MD, PhD, Harriet Van Vleet Endowment Professor in Basic Oncology Research, Junming Yue, PhD, associate professor in the Department of Pathology, Sue Chin Lee, PhD, in the Department of Physiology, and David Schwartz, MD, chair of the Department of Radiation Oncology, are part of a scientific leadership group… Read More
UTHSC-led team lands cancer immunotherapy grant
Cancer immunotherapy is a form of cancer treatment that uses the body’s immune system to prevent, control, and eliminate cancer, and it’s become a popular method. But it often fails to cure patients, as the cancer cells can sidestep and inhibit the body’s anti-tumor response. Now, however, a team at the University of Tennessee Health… Read More
UTHSC-led team receives $3.16 million from National Cancer Institute for cancer immunotherapy drug development
A UTHSC-led team has received $3.16 million from the National Cancer Institute to develop a drug that boosts the immune system response in cancer patients to destroy tumor cells. Gabor Tigyi, MD, PhD, Harriet Van Vleet Endowment Professor in the Department of Physiology, is the lead investigator. Sue Chin Lee, PhD, associate professor in the… Read More
‘We were so damn lucky to find this’: Tennesseans close to developing radiation exposure drug
Scientists in Tennessee are developing a promising drug they desperately hope will never be used. It’s a treatment that could rescue people from gastrointestinal acute radiation syndrome. In blunt terms, radiation poisoning. “We were so damn lucky to find this mechanism that nature invented for us,” said Dr. Gabor Tigyi, a cell biologist and cancer researcher… Read More
Live at 9: Tennessee Institute of Regenerative Medicine explains its research at UTHSC
The Tennessee Institute of Regenerative Medicine is doing cutting-edge work at the University of Tennessee Health Science Center, and their goal is to translate scientific discoveries into new therapies for people suffering from organ damage. To learn more, we talked with executive director Dr. Gabor Tigyi and UTHSC’s vice chancellor for research, Dr. Steve Goodman.